These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 21905023

  • 1. Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells.
    Bergmann C, Wild CA, Narwan M, Lotfi R, Lang S, Brandau S.
    Eur J Immunol; 2011 Dec; 41(12):3564-73. PubMed ID: 21905023
    [Abstract] [Full Text] [Related]

  • 2. CD4+ CD25+ Foxp3+ IFNγ+ CD178+ human induced Treg (iTreg) contribute to suppression of alloresponses by apoptosis of responder cells.
    Daniel V, Sadeghi M, Wang H, Opelz G.
    Hum Immunol; 2013 Feb; 74(2):151-62. PubMed ID: 23017670
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C, Zhang J, Niu J, Zhou Z, Zhang J, Tian Z.
    Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
    [Abstract] [Full Text] [Related]

  • 4. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
    Konjević G, Mirjačić Martinović K, Vuletić A, Babović N.
    Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
    [Abstract] [Full Text] [Related]

  • 5. Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells.
    Vacca P, Cantoni C, Prato C, Fulcheri E, Moretta A, Moretta L, Mingari MC.
    Int Immunol; 2008 Nov; 20(11):1395-405. PubMed ID: 18815119
    [Abstract] [Full Text] [Related]

  • 6. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F, Ménard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel L.
    J Exp Med; 2005 Oct 17; 202(8):1075-85. PubMed ID: 16230475
    [Abstract] [Full Text] [Related]

  • 7. IL-2/IL-18 prevent the down-modulation of NKG2D by TGF-beta in NK cells via the c-Jun N-terminal kinase (JNK) pathway.
    Song H, Hur DY, Kim KE, Park H, Kim T, Kim CW, Bang S, Cho DH.
    Cell Immunol; 2006 Jul 17; 242(1):39-45. PubMed ID: 17070508
    [Abstract] [Full Text] [Related]

  • 8. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
    Bose A, Chakraborty K, Sarkar K, Goswami S, Chakraborty T, Pal S, Baral R.
    J Immunother; 2009 Jan 17; 32(1):42-53. PubMed ID: 19307993
    [Abstract] [Full Text] [Related]

  • 9. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C.
    Exp Hematol; 2007 Mar 01; 35(3):416-25. PubMed ID: 17309822
    [Abstract] [Full Text] [Related]

  • 14. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation.
    Vacca P, Martini S, Garelli V, Passalacqua G, Moretta L, Mingari MC.
    Eur J Immunol; 2013 Feb 01; 43(2):550-61. PubMed ID: 23192659
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW, Liao CH, Ying C, Chang CJ, Lin CM.
    Clin Immunol; 2006 Apr 01; 119(1):21-31. PubMed ID: 16406844
    [Abstract] [Full Text] [Related]

  • 18. Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4.
    Salvucci O, Mami-Chouaib F, Moreau JL, Thèze J, Chehimi J, Chouaib S.
    Eur J Immunol; 1996 Nov 01; 26(11):2736-41. PubMed ID: 8921963
    [Abstract] [Full Text] [Related]

  • 19. IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.
    Kloess S, Huenecke S, Piechulek D, Esser R, Koch J, Brehm C, Soerensen J, Gardlowski T, Brinkmann A, Bader P, Passweg J, Klingebiel T, Schwabe D, Koehl U.
    Eur J Immunol; 2010 Nov 01; 40(11):3255-67. PubMed ID: 21061445
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolic acid-treated dendritic cells generate regulatory CD4+ T cells that suppress CD8+ T cells' allocytotoxicity.
    Kazma I, Lemoine R, Herr F, Chadet S, Meley D, Velge-Roussel F, Lebranchu Y, Baron C.
    Int Immunol; 2014 Mar 01; 26(3):173-81. PubMed ID: 24222014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.